Lack of change in blood pressure and arterial stiffness after high dairy intake in hyperinsulinemic subjects: a cross-over randomized controlled trial.

arterial pressure arterial stiffness augmentation index carotid-femoral pulse wave velocity dairy products hyperinsulinemia

Journal

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
ISSN: 1715-5320
Titre abrégé: Appl Physiol Nutr Metab
Pays: Canada
ID NLM: 101264333

Informations de publication

Date de publication:
08 Nov 2023
Historique:
pubmed: 8 11 2023
medline: 8 11 2023
entrez: 8 11 2023
Statut: aheadofprint

Résumé

To evaluate the effects of high dairy (HD) (≥4 servings/day), compared to adequate dairy (AD) (2-3 servings/day as per Canada's Food Guide for Healthy Eating (2007)), on blood pressure (BP) and measures of arterial stiffness in hyperinsulinemic subjects. In this cross-over clinical trial, hyperinsulinemic adults were randomized to AD and HD for 6 weeks. Anthropometric, glycemic, and lipid parameters were analyzed and dietary intake was evaluated; BP, carotid-femoral pulse wave velocity, augmentation index, and measures of arterial stiffness were assessed. Twenty-seven participants completed the study. Dairy intake was 2.2 ± 1.2 servings/day during AD. In addition, lower total and low-density lipoprotein (LDL) cholesterol were observed without significant change in BP or arterial stiffness between before and after AD. During HD, the subjects consumed 5.8 ± 1.9 servings/day of dairy products, providing a higher intake of protein, saturated fat, calcium, phosphorus, sodium, and potassium compared to the baseline diet. After the HD, subjects had higher body fat, fasting insulin, homeostatic model assessment for insulin resistance (HOMA-IR) index, and triglycerides without altering BP or arterial stiffness compared to before HD. Overall, adequate or high intake of total dairy did not modify BP or arterial stiffness in hyperinsulinemic adults after 6 weeks.

Identifiants

pubmed: 37939366
doi: 10.1139/apnm-2023-0053
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

All authors state that there is no conflict of interest.

Auteurs

Hana Arghavani (H)

Endocrinology and Nephrology Axis, CHU de Québec Research Center-Université Laval, Québec, QC, Canada.

Sarah O'Connor (S)

Institut universitaire de cardiologie et pneumologie de Québec (IUCPQ) Research Centre, Québec, QC, Canada.
Faculty of Pharmacy, Université Laval, Québec, QC, Canada.

Catherine Fortier (C)

Endocrinology and Nephrology Axis, CHU de Québec Research Center-Université Laval, Québec, QC, Canada.
Department of Kinesiology, Université Laval, Québec, QC, Canada.

Iwona Rudkowska (I)

Endocrinology and Nephrology Axis, CHU de Québec Research Center-Université Laval, Québec, QC, Canada.
Department of Kinesiology, Université Laval, Québec, QC, Canada.

Classifications MeSH